BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35053585)

  • 21. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
    Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
    J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician.
    Dronkers EA; Mes SW; Wieringa MH; van der Schroeff MP; Baatenburg de Jong RJ
    BMC Cancer; 2015 Jul; 15():515. PubMed ID: 26163015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Rühle A; Stromberger C; Haehl E; Senger C; David H; Stoian R; Zamboglou C; Knopf A; Budach V; Grosu AL; Nicolay NH
    Radiother Oncol; 2021 Jan; 154():276-282. PubMed ID: 33245947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
    Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
    Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
    Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients.
    Haase K; Piwonski I; Stromberger C; Thieme N; Heiland M; Beck-Broichsitter B; Hofmann VM; Kofla G; Sander S; Keilholz U; Neumann K; Stölzel K; Olze H; Arens P; Dommerich S; Coordes A
    Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3941-3953. PubMed ID: 33492419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to Surveillance Guidelines in Nondysplastic Barrett's Esophagus.
    Dalal KS; Coffing J; Imperiale TF
    J Clin Gastroenterol; 2018 Mar; 52(3):217-222. PubMed ID: 27984402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac comorbidity in head and neck cancer patients and its influence on cancer treatment selection and mortality: a prospective cohort study.
    Simeoni R; Breitenstein K; Eßer D; Guntinas-Lichius O
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2765-72. PubMed ID: 26581475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery.
    Yoo SH; Roh JL; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1343-51. PubMed ID: 26979590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
    Hepp Z; Lage MJ; Espaillat R; Gossain VV
    J Med Econ; 2018 Sep; 21(9):912-919. PubMed ID: 29865926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group.
    Firat S; Byhardt RW; Gore E
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):357-64. PubMed ID: 12243808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head and neck squamous cell carcinoma in young patients: a 26-year clinicopathologic retrospective study in a Brazilian specialized center.
    Tomo S; Neto SC; Collado FU; Sundefeld ML; Bernabé DG; Biasoli ÉR; Miyahara GI
    Med Oral Patol Oral Cir Bucal; 2020 May; 25(3):e416-e424. PubMed ID: 32134900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive neck node metastases (N3) in head and neck squamous carcinoma: is radical treatment warranted?
    Jones AS; Goodyear PW; Ghosh S; Husband D; Helliwell TR; Jones TM
    Otolaryngol Head Neck Surg; 2011 Jan; 144(1):29-35. PubMed ID: 21493383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.